Skip to main content

Nasonex Disease Interactions

There are 4 disease interactions with Nasonex (mometasone nasal).

Moderate

Mometasone nasal (applies to Nasonex) hepatic impairment

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease

Mometasone nasal should be used with caution in patients with impaired liver function. Concentrations of mometasone appear to increase with severity of liver dysfunction.

References

  1. "Product Information. Ryaltris (mometasone-olopatadine nasal)." Hikma Americas, Inc ORIG-1 (2022):
  2. "Product Information. Nasonex (mometasone nasal)." Schering-Plough Corporation SUPPL-56 (2022):
Moderate

Mometasone nasal (applies to Nasonex) hyperadrenocorticism

Moderate Potential Hazard, Moderate plausibility.

Hypercorticism and adrenal suppression may occur when nasal corticosteroids, including mometasone nasal, are used in patients at risk for such effects. It is important that the recommended dosage of mometasone nasal is not exceeded.

References

  1. "Product Information. Ryaltris (mometasone-olopatadine nasal)." Hikma Americas, Inc ORIG-1 (2022):
  2. "Product Information. Nasonex (mometasone nasal)." Schering-Plough Corporation SUPPL-56 (2022):
Moderate

Mometasone nasal (applies to Nasonex) infections

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Infection - Bacterial/Fungal/Protozoal/Viral, Tuberculosis -- Latent

Patients who are using drugs that suppress the immune system, such as corticosteroids (including mometasone nasal), are more susceptible to infections than healthy subjects. Mometasone nasal should be used with caution, if at all, in patients with active or quiescent tuberculosis infection of the respiratory tract, untreated local or systemic fungal or bacterial infections, systemic viral or parasitic infections, or ocular herpes simplex due to the potential for worsening of these infections.

References

  1. "Product Information. Ryaltris (mometasone-olopatadine nasal)." Hikma Americas, Inc ORIG-1 (2022):
  2. "Product Information. Nasonex (mometasone nasal)." Schering-Plough Corporation SUPPL-56 (2022):
Moderate

Mometasone nasal (applies to Nasonex) ocular toxicities

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Cataracts, Glaucoma/Intraocular Hypertension

Nasal and inhaled corticosteroids, including mometasone nasal, can result in the development of glaucoma and/or cataracts. Close monitoring is warranted in patients with a change in vision or history of increased intraocular pressure, glaucoma, and/or cataracts. Referral to an ophthalmologist should be considered for patients who develop ocular symptoms or use mometasone nasal long term.

References

  1. "Product Information. Ryaltris (mometasone-olopatadine nasal)." Hikma Americas, Inc ORIG-1 (2022):
  2. "Product Information. Nasonex (mometasone nasal)." Schering-Plough Corporation SUPPL-56 (2022):

Nasonex drug interactions

There are 33 drug interactions with Nasonex (mometasone nasal).


Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.